Evolution of the clinical simulation approach to assess digital health technologies.

Lau, Karen; Halligan, Jack; Fontana, Gianluca; Guo, Chaohui; O'Driscoll, Fiona K; Prime, Matthew; Ghafur, Saira

Lau, Karen; Halligan, Jack; Fontana, Gianluca; Guo, Chaohui; O'Driscoll, Fiona K; Prime, Matthew; Ghafur, Saira.

Afiliação

Lau K; St George's University of London and London School of Hygiene & Tropical Medicine, London, UK; Research Manager at Samuel Hall, London, UK.
Halligan J; Imperial College London, London, UK; co-founder and COO at Prova Health, London, UK.
Fontana G; Imperial College London, London, UK; co-founder and CEO at Prova Health, London, UK.
Guo C; Roche Diagnostics, Basel, Switzerland.
O'Driscoll FK; Imperial College London, London, UK.
Prime M; Roche Diagnostics, Basel, Switzerland; co-founder at Open Medical, London, UK; honorary research fellow at the Institute of Global Health Innovation, Imperial College London, London, UK.
Ghafur S; Imperial College London, London, UK; co-founder at Prova Health, London, UK; co-founder at Psyma, London, UK; honorary consultant in Respiratory Medicine at Imperial College Healthcare NHS Trust, London, UK.

Future Healthc J ; 10(2): 173-175, 2023 Jul.

Article em En | MEDLINE | ID: mdl-37786639

Palavras-chave

cancer services; digital health; digital health technology; regulation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Future Healthc J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google